AN2 Therapeutics vs Juno Therapeutics
AN2 Therapeutics vs Juno Therapeutics, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: AN2 Therapeutics is on 46/100 and Juno Therapeutics on 66/100.
Where each one leads
AN2 Therapeutics
Leads on none of the measures we hold for both companies.
Juno Therapeutics
- our overall score: 66/100 against 46/100
- funding raised: $317M against $132M
At a glance
| Measure | AN2 Therapeutics | Juno Therapeutics |
|---|---|---|
| What it is | Clinical-stage biopharmaceutical company developing novel boron-based small molecule therapeutics for rare infectious diseases and oncology. | Biotechnology company focused on developing cancer immunotherapies. |
| Category | Biotechnology, Pharmaceuticals, Healthcare, Drug Discovery | Biotechnology, Pharmaceuticals, Cancer Immunotherapy, Cart |
| Sells toBusiness model | B2B | B2B |
| Offering | Biopharmaceutical | Services |
| Founded | 2018 | 2013 |
| Headquarters | Menlo Park, United States | Seattle, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | AN2 Therapeutics | Juno Therapeutics |
|---|---|---|
| Total funding | $132M | $317M |
| Latest round | Private Placement | Series B |
| Valuation | $1.1B | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | AN2 Therapeutics | Juno Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 46/100 | 66/100 |
| Traction | 40/100 | 40/100 |
| Team | 70/100 | 90/100 |
| Community | Not published | 15/100 |
| Search visibility | 12/100 | 15/100 |
| Quality | 55/100 | 87/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (32/100) | Not published |
| Domain ratingLink authority, 0-100 | 29/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | AN2 Therapeutics | Juno Therapeutics |
|---|---|---|
| Hosting | AWS | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Google Analytics 4 | Not detected |
AN2 Therapeutics vs Juno Therapeutics: common questions
Which is better, AN2 Therapeutics or Juno Therapeutics?
On our 0-100 score Juno Therapeutics rates higher (66/100 against 46/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do AN2 Therapeutics and Juno Therapeutics compare on the numbers?
Juno Therapeutics leads on our overall score (66/100 against 46/100), funding raised ($317M against $132M).
Read the full AN2 Therapeutics review and pricing or the Juno Therapeutics review and pricing. You can also browse other AN2 Therapeutics alternatives we track.